Following years of record-breaking activity, biopharma and medtech dealmaking continued to see declines across its subsectors in the second quarter of 2022.
J.P. Morgan’s Biopharma and Medtech Deals and Venture Outlook report examines the sector at midyear to provide insights on industry trends we might see for the remainder of 2022. The report, powered by DealForma, highlights:
What does this mean for the rest of 2022?
Read the full report to get all the insights.
Giving thanks: 5 things we (and markets) are grateful for
Nov 22, 2023
Despite a bumpy road for investors in 2023, there are a bounty of reasons to be optimistic leading up to the new year.
Is the coast clear? Investing amid the rally
Nov 17, 2023
As we gear up for the final weeks of the year, we think the key is to stay focused. Even with the rally, we see opportunity ahead.
October 2023 CPI report: Inflation falls to 3.2%
Nov 15, 2023
Headline inflation showed cooling in October from 3.7% to 3.2%, a sign that it may be trending in the right direction.
Eye on the Market: Not that 70’s show
Nov 14, 2023
It’s hard to make sense of everything going on in the world and what it all means for markets. Read about the impacts of geopolitics and other factors in the latest Eye on the Market.
2024 Elections: 3 thoughts on the year ahead
Nov 10, 2023
Elections may seem like a big deal in the moment, but historically have had little bearing on what path the economy and market ultimately take.
Jobs report October 2023: 150,000 jobs added, lower than forecast
Nov 06, 2023
The U.S. economy added 150,000 jobs in October, marking a slowdown in the pace of hiring.
Are markets finally finding direction?
Nov 03, 2023
Markets hate uncertainty and thrive on clarity. A better sense of the path forward may offer more runway to rally.
November 2023 Fed meeting: Rates hold steady
Nov 02, 2023
The Federal Reserve Bank took a wait-and-see approach to further rate hikes as it held its overnight interest rate steady in November.
You're now leaving J.P. Morgan
J.P. Morgan’s website and/or mobile terms, privacy and security policies don’t apply to the site or app you're about to visit. Please review its terms, privacy and security policies to see how they apply to you. J.P. Morgan isn’t responsible for (and doesn’t provide) any products, services or content at this third-party site or app, except for products and services that explicitly carry the J.P. Morgan name.